The pathogenesis of thromboembolic disease in covid-19 patients: Could be a catastrophic antiphospholipid syndrome?
- PMID: 32788116
- PMCID: PMC7319923
- DOI: 10.1016/j.thromres.2020.06.042
The pathogenesis of thromboembolic disease in covid-19 patients: Could be a catastrophic antiphospholipid syndrome?
Keywords: Antiphospholipid antibodies; Autopsies; CAPS; COVID-19; Thromboembolism.
Conflict of interest statement
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Comment on
-
Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study.Lancet Infect Dis. 2020 Oct;20(10):1135-1140. doi: 10.1016/S1473-3099(20)30434-5. Epub 2020 Jun 8. Lancet Infect Dis. 2020. PMID: 32526193 Free PMC article.
References
-
- Taylor F.B., Jr., Toh C.H., Hoots W.K., Wada H., Levi M. Towards a definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. J. Thromb. Haemost. 2001;86:1327–1330. - PubMed
-
- Rodriguez-Pinto I., Moitinho M., Santacreu I., Shoenfeld Y., Erkan D., Espinosa G. Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of 500 patients from the International CAPS Registry. Autoimmun. Rev. 2016;15:1120–1124. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous